Basilea Pharmaceutica (OTCMKTS:BPMUF) Reaches New 52-Week High – Here’s Why

Basilea Pharmaceutica AG (OTCMKTS:BPMUF)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $52.83 and last traded at $52.83, with a volume of 0 shares trading hands. The stock had previously closed at $52.83.

Analysts Set New Price Targets

Separately, HC Wainwright upgraded shares of Basilea Pharmaceutica to a “strong-buy” rating in a research note on Monday, September 23rd.

Basilea Pharmaceutica Price Performance

The firm has a 50 day simple moving average of $52.77 and a two-hundred day simple moving average of $50.41.

Basilea Pharmaceutica Company Profile

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.